Based on observation of CDIM9 with other tumor cells [23,24], we analyzed the levels of the transcription factors nonsteroidal anti-inflammatory drug-activated gene (NAG)-1 and activating transcription factor (ATF)3 in the basal-like breast cancer cells treated and untreated with CDIM9. This evidence concerns the gene ATF3 and breast carcinoma.